![](/img/cover-not-exists.png)
Are ALK rearrangement variants promising predictive biomarker of ALK tyrosine kinase inhibitors efficacy?
Duruisseaux, M., Mc Leer-Florin, A., Moro-Sibilot, D., Cadranel, J.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx116
Date:
June, 2017
File:
PDF, 42 KB
english, 2017